ACHIEVEMENT OF CLINICAL AND ENDOSCOPIC OUTCOMES BY BASELINE CORTICOSTEROID USE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO RECEIVED RISANKIZUMAB INDUCTION TREATMENT: A POST-HOC ANALYSIS OF THE INSPIRE STUDY

被引：0

作者：

Bossuyt, Peter

Louis, Edouard

Gecse, Krisztina

Abreu, Maria T.

Gionchetti, Paolo

Rubin, David T.

Marced, Elena

Gonzalez, Yuri Sanchez

Hecht, Patrick

Kalabic, Jasmina

Vladea, Ramona C.

Zhang, Yafei

Reinisch, Walter

机构：

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Su1773

引用

页码：S806 / S807

页数：2